Skip to main content
. 2025 Mar 31;12:1541651. doi: 10.3389/fcvm.2025.1541651

Table 2.

Comparison of patients admitted through different modes of admission.

Variables Outpatient (n = 111) Emergency (n = 40) Transferred (n = 61)
Demographic characteristics
Age, years 1.33 (0.38,7.50) 0.46 (0.31,3.25) 0.83 (0.33,5.00)
Sex
Girl 41 (36.94%) 13 (32.50%) 20 (32.79%)
Boy 70 (63.06%) 27 (67.50%) 41 (67.21%)
Modified ROSS classification
I–II 68 (61.26%) 10 (25.00%)* 8 (13.11%)*
III–IV 43 (38.74%) 30 (75.00%)* 53 (86.89%)*
Diagnostic-related
Initial Diagnosis 67 (60.36%) 31 (77.50%)* 52 (85.25%)*
Type of CM
HCM 90 (81.08%) 34 (85.00%) 45 (73.77%)
RCM 16 (14.41%) 6 (15.00%) 14 (22.95%)
RP-HCM 5 (4.50%) 0 (0.00%) 2 (3.28%)
Primary combined disease
Infection 76 (68.47%) 35 (87.50%)* 49 (80.33%)*
Heart failure 53 (47.75%) 20 (50.00%) 36 (59.02%)
Arrhythmia 26 (23.42%) 4 (10.00%) 13 (21.31%)
Outcomes
Length of hospital stay, days 12.74 ± 12.79 10.40 ± 12.44 12.02 ± 9.08
Hospitalization outcome
Survival 105 (94.59%) 38 (95.00%) 58 (95.08%)
Death 6 (5.41%) 2 (5.00%) 3 (4.92%)
Duration of follow-up, years 5.00 (2.52,7.41) 3.39 (0.74,5.03) 4.05 (0.50,8.83)
Age at the end of follow-up, years 8.43 (5.67,12.33) 5.32 (2.66,9.70) 8.26 (2.52,13.70)
Follow-up outcomes
Death 14 (12.61%) 11 (27.50%)* 18 (29.51%)*
Survival 92 (82.88) 29 (72.50)* 37 (60.66)*
Lost 5 (4.50%) NA 6 (9.84%)*

Transferred, transferred from other medical institutions group; HCM, hypertrophic cardiomyopathy; RCM, restrictive cardiomyopathy; RP-HCM, hypertrophic cardiomyopathy with restrictive phenotype.

*

Comparison with outpatient group, P < 0.05.